BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28105651)

  • 21. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
    Sur MD; In H; Sharpe SM; Baker MS; Weichselbaum RR; Talamonti MS; Posner MC
    Ann Surg Oncol; 2015 Jul; 22(7):2209-17. PubMed ID: 25476031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
    Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
    JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?
    Tsilimigras DI; Hyer JM; Paredes AZ; Moris D; Sahara K; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Sasaki K; Aucejo F; Zhang XF; Pawlik TM
    Ann Surg Oncol; 2021 Apr; 28(4):1970-1978. PubMed ID: 33259043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
    Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
    Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.
    Cillo U; Spolverato G; Vitale A; Ejaz A; Lonardi S; Cosgrove D; Pawlik TM
    World J Surg; 2015 Oct; 39(10):2500-9. PubMed ID: 26148521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.
    Spolverato G; Yakoob MY; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; Pawlik TM
    Ann Surg Oncol; 2015 Nov; 22(12):4020-8. PubMed ID: 25762481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
    Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
    Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
    Li XH; Zhao CY; Zhou EL; Lin XJ
    BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Re-resection for recurrent intrahepatic cholangiocarcinoma].
    Murakami S; Ajiki T; Okazaki T; Matsumoto T; Yoshida Y; Shinozaki K; Goto T; Asari S; Shinzeki M; Kido M; Matsumoto I; Fukumoto T; Ku Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1468-70. PubMed ID: 25731221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma.
    Yeh CN; Hsieh FJ; Chiang KC; Chen JS; Yeh TS; Jan YY; Chen MF
    Drug Des Devel Ther; 2015; 9():163-74. PubMed ID: 25552905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients.
    Tsilimigras DI; Hyer JM; Moris D; Sahara K; Bagante F; Guglielmi A; Aldrighetti L; Alexandrescu S; Marques HP; Shen F; Koerkamp BG; Endo I; Pawlik TM;
    J Surg Oncol; 2019 Aug; 120(2):206-213. PubMed ID: 31025380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
    Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
    Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
    Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
    HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of major vascular resection in patients with intrahepatic cholangiocarcinoma.
    Ali SM; Clark CJ; Zaydfudim VM; Que FG; Nagorney DM
    Ann Surg Oncol; 2013 Jun; 20(6):2023-8. PubMed ID: 23263702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.